|Identification of CSPα clients reveals a role in dynamin 1 regulation|
YQ Zhang, MX Henderson, CM Colangelo, SD Ginsberg, C Bruce, T Wu, ...
Neuron 74 (1), 136-150, 2012
|Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis|
MX Henderson, EJ Cornblath, A Darwich, B Zhang, H Brown, ...
Nature neuroscience 22 (8), 1248-1257, 2019
|Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation|
MX Henderson, GS Wirak, Y Zhang, F Dai, SD Ginsberg, N Dolzhanskaya, ...
Acta neuropathologica 131 (4), 621-637, 2016
|α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies|
MX Henderson, JQ Trojanowski, VMY Lee
Neuroscience letters 709, 134316, 2019
|Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease|
MX Henderson, M Sengupta, JQ Trojanowski, VMY Lee
Acta neuropathologica communications 7 (1), 1-16, 2019
|Glucose sensitivity of mouse olfactory bulb neurons is conveyed by a voltage‐gated potassium channel|
K Tucker, S Cho, N Thiebaud, MX Henderson, DA Fadool
The Journal of physiology 591 (10), 2541-2561, 2013
|LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons|
MX Henderson, C Peng, JQ Trojanowski, VMY Lee
Acta neuropathologica communications 6 (1), 1-11, 2018
|LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice|
MX Henderson, M Sengupta, I McGeary, B Zhang, MF Olufemi, H Brown, ...
Acta neuropathologica communications 7 (1), 1-12, 2019
|Unbiased proteomics of early Lewy body formation model implicates active microtubule affinity-regulating kinases (MARKs) in synucleinopathies|
MX Henderson, CHY Chung, DM Riddle, B Zhang, RJ Gathagan, ...
Journal of Neuroscience 37 (24), 5870-5884, 2017
|Glucocerebrosidase activity modulates neuronal susceptibility to pathological α-Synuclein insult|
MX Henderson, S Sedor, I McGeary, EJ Cornblath, C Peng, DM Riddle, ...
Neuron 105 (5), 822-836. e7, 2020
|Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease|
MX Henderson, DJ Covell, CHY Chung, RM Pitkin, RM Sandler, ...
Neurobiology of disease 136, 104712, 2020
|Tau pathology spreads between anatomically-connected regions of the brain and is modulated by a LRRK2 mutation|
M Henderson, EJ Cornblath, HL Li, L Changolkar, B Zhang, HJ Brown, ...
|LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons|
MX Henderson, L Changolkar, JQ Trojanowski, VMY Lee
Journal of Parkinson's Disease, 1-10, 2021